nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—MMP9—thoracic aortic aneurysm	0.831	1	CbGaD
Minocycline—MMP9—tunica intima—thoracic aortic aneurysm	0.0141	0.256	CbGeAlD
Minocycline—IL1B—leg—thoracic aortic aneurysm	0.0106	0.192	CbGeAlD
Minocycline—CASP3—artery—thoracic aortic aneurysm	0.00724	0.131	CbGeAlD
Minocycline—IL1B—artery—thoracic aortic aneurysm	0.00579	0.105	CbGeAlD
Minocycline—MMP9—artery—thoracic aortic aneurysm	0.00482	0.0875	CbGeAlD
Minocycline—VEGFA—EPHA-mediated growth cone collapse—MYH11—thoracic aortic aneurysm	0.00328	0.0287	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—FBN1—thoracic aortic aneurysm	0.00272	0.0238	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—TGFBR1—thoracic aortic aneurysm	0.00234	0.0204	CbGpPWpGaD
Minocycline—CASP1—spinal cord—thoracic aortic aneurysm	0.00233	0.0422	CbGeAlD
Minocycline—CYCS—spinal cord—thoracic aortic aneurysm	0.00224	0.0406	CbGeAlD
Minocycline—CASP3—Copper homeostasis—ADAM17—thoracic aortic aneurysm	0.00223	0.0195	CbGpPWpGaD
Minocycline—VEGFA—Hypertrophy Model—ADAM10—thoracic aortic aneurysm	0.00221	0.0193	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—ADAM17—thoracic aortic aneurysm	0.0022	0.0192	CbGpPWpGaD
Minocycline—MMP9—Collagen degradation—ADAM17—thoracic aortic aneurysm	0.00199	0.0174	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—ADAM17—thoracic aortic aneurysm	0.00197	0.0173	CbGpPWpGaD
Minocycline—VEGFA—Beta1 integrin cell surface interactions—FBN1—thoracic aortic aneurysm	0.00193	0.0169	CbGpPWpGaD
Minocycline—CASP3—spinal cord—thoracic aortic aneurysm	0.00192	0.0348	CbGeAlD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—ACTA2—thoracic aortic aneurysm	0.00185	0.0162	CbGpPWpGaD
Minocycline—CASP3—Posttranslational regulation of adherens junction stability and dissassembly—ADAM10—thoracic aortic aneurysm	0.00182	0.0159	CbGpPWpGaD
Minocycline—VEGFA—cardiac atrium—thoracic aortic aneurysm	0.00179	0.0325	CbGeAlD
Minocycline—CASP3—p75(NTR)-mediated signaling—ADAM17—thoracic aortic aneurysm	0.00178	0.0155	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—ADAM10—thoracic aortic aneurysm	0.00171	0.0149	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MYH11—thoracic aortic aneurysm	0.00168	0.0146	CbGpPWpGaD
Minocycline—VEGFA—Glypican 1 network—TGFBR2—thoracic aortic aneurysm	0.00166	0.0145	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—SMAD3—thoracic aortic aneurysm	0.0016	0.014	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—ADAM17—thoracic aortic aneurysm	0.00159	0.0139	CbGpPWpGaD
Minocycline—CASP3—p75 NTR receptor-mediated signalling—ADAM17—thoracic aortic aneurysm	0.00155	0.0135	CbGpPWpGaD
Minocycline—IL1B—spinal cord—thoracic aortic aneurysm	0.00153	0.0278	CbGeAlD
Minocycline—MMP9—Collagen degradation—ADAM10—thoracic aortic aneurysm	0.00152	0.0133	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—ADAM10—thoracic aortic aneurysm	0.00151	0.0132	CbGpPWpGaD
Minocycline—VEGFA—spinal cord—thoracic aortic aneurysm	0.00151	0.0273	CbGeAlD
Minocycline—VEGFA—EPH-Ephrin signaling—MYH11—thoracic aortic aneurysm	0.00145	0.0127	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—ADAM17—thoracic aortic aneurysm	0.00145	0.0127	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—ADAM17—thoracic aortic aneurysm	0.00144	0.0126	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—SMAD3—thoracic aortic aneurysm	0.00143	0.0125	CbGpPWpGaD
Minocycline—CASP3—Syndecan-2-mediated signaling events—MMP2—thoracic aortic aneurysm	0.00128	0.0112	CbGpPWpGaD
Minocycline—MMP9—spinal cord—thoracic aortic aneurysm	0.00128	0.0232	CbGeAlD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—ADAM10—thoracic aortic aneurysm	0.00126	0.011	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFBR1—thoracic aortic aneurysm	0.00126	0.011	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—TGFB2—thoracic aortic aneurysm	0.00125	0.011	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—ADAM10—thoracic aortic aneurysm	0.00122	0.0107	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFB2—thoracic aortic aneurysm	0.00121	0.0106	CbGpPWpGaD
Minocycline—IL1B—IL1 and megakaryotyces in obesity—MMP9—thoracic aortic aneurysm	0.00121	0.0105	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—SMAD3—thoracic aortic aneurysm	0.00115	0.0101	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—ADAM17—thoracic aortic aneurysm	0.00115	0.0101	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—ADAM10—thoracic aortic aneurysm	0.00111	0.0097	CbGpPWpGaD
Minocycline—VEGFA—Beta3 integrin cell surface interactions—TGFBR2—thoracic aortic aneurysm	0.00111	0.00968	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—ADAM10—thoracic aortic aneurysm	0.00111	0.00966	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—TGFB2—thoracic aortic aneurysm	0.00109	0.00952	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—FBN1—thoracic aortic aneurysm	0.00106	0.00923	CbGpPWpGaD
Minocycline—MMP9—Matrix Metalloproteinases—MMP2—thoracic aortic aneurysm	0.00103	0.00899	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—ADAM17—thoracic aortic aneurysm	0.00101	0.00879	CbGpPWpGaD
Minocycline—MMP9—Osteopontin-mediated events—MMP2—thoracic aortic aneurysm	0.001	0.00876	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—ADAM17—thoracic aortic aneurysm	0.000985	0.00861	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—MMP2—thoracic aortic aneurysm	0.000977	0.00854	CbGpPWpGaD
Minocycline—MMP9—amb2 Integrin signaling—MMP2—thoracic aortic aneurysm	0.000977	0.00854	CbGpPWpGaD
Minocycline—MMP9—Activation of Matrix Metalloproteinases—MMP2—thoracic aortic aneurysm	0.000977	0.00854	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000949	0.00829	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—ADAM17—thoracic aortic aneurysm	0.000929	0.00812	CbGpPWpGaD
Minocycline—VEGFA—Platelet degranulation—TGFB2—thoracic aortic aneurysm	0.000911	0.00796	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.000895	0.00782	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFBR1—thoracic aortic aneurysm	0.000871	0.00761	CbGpPWpGaD
Minocycline—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—thoracic aortic aneurysm	0.00087	0.0076	CbGpPWpGaD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—TGFB2—thoracic aortic aneurysm	0.000868	0.00759	CbGpPWpGaD
Minocycline—MMP9—Collagen degradation—MMP2—thoracic aortic aneurysm	0.000852	0.00744	CbGpPWpGaD
Minocycline—CASP3—TWEAK Signaling Pathway—MMP9—thoracic aortic aneurysm	0.000851	0.00744	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.000838	0.00733	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFB2—thoracic aortic aneurysm	0.000835	0.0073	CbGpPWpGaD
Minocycline—VEGFA—Integrins in angiogenesis—TGFBR2—thoracic aortic aneurysm	0.000816	0.00713	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP2—thoracic aortic aneurysm	0.000808	0.00707	CbGpPWpGaD
Minocycline—VEGFA—Angiogenesis—MMP9—thoracic aortic aneurysm	0.000802	0.00701	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—MMP2—thoracic aortic aneurysm	0.000801	0.007	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—SMAD3—thoracic aortic aneurysm	0.000801	0.007	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP2—thoracic aortic aneurysm	0.000789	0.00689	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFBR1—thoracic aortic aneurysm	0.000788	0.00689	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000786	0.00687	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—MYLK—thoracic aortic aneurysm	0.000779	0.00681	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—ADAM10—thoracic aortic aneurysm	0.00077	0.00673	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFB2—thoracic aortic aneurysm	0.000756	0.00661	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—ADAM10—thoracic aortic aneurysm	0.000738	0.00645	CbGpPWpGaD
Minocycline—CYCS—AGE/RAGE pathway—MMP9—thoracic aortic aneurysm	0.000735	0.00642	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—FBN1—thoracic aortic aneurysm	0.000733	0.00641	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—SMAD3—thoracic aortic aneurysm	0.00072	0.0063	CbGpPWpGaD
Minocycline—MMP9—EPH-ephrin mediated repulsion of cells—MMP2—thoracic aortic aneurysm	0.000706	0.00617	CbGpPWpGaD
Minocycline—VEGFA—HIF-1-alpha transcription factor network—SMAD3—thoracic aortic aneurysm	0.000695	0.00608	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—SMAD3—thoracic aortic aneurysm	0.000694	0.00606	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.000673	0.00588	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—ADAM10—thoracic aortic aneurysm	0.00064	0.0056	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—MMP2—thoracic aortic aneurysm	0.000626	0.00547	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MYH11—thoracic aortic aneurysm	0.000623	0.00544	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP2—thoracic aortic aneurysm	0.000621	0.00543	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.000618	0.0054	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—MMP9—thoracic aortic aneurysm	0.000608	0.00531	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—ADAM17—thoracic aortic aneurysm	0.000607	0.0053	CbGpPWpGaD
Minocycline—CASP3—AGE/RAGE pathway—MMP9—thoracic aortic aneurysm	0.000593	0.00518	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—TGFB2—thoracic aortic aneurysm	0.000582	0.00508	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000572	0.005	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—ADAM17—thoracic aortic aneurysm	0.000569	0.00497	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—MMP2—thoracic aortic aneurysm	0.000561	0.00491	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TGFBR2—thoracic aortic aneurysm	0.000559	0.00489	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—MMP2—thoracic aortic aneurysm	0.000548	0.00479	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MYH11—thoracic aortic aneurysm	0.00054	0.00472	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—ADAM17—thoracic aortic aneurysm	0.000524	0.00458	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TGFBR1—thoracic aortic aneurysm	0.000474	0.00414	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—thoracic aortic aneurysm	0.000469	0.0041	CbGpPWpGaD
Minocycline—CASP3—Degradation of the extracellular matrix—MMP9—thoracic aortic aneurysm	0.000467	0.00408	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—ADAM10—thoracic aortic aneurysm	0.000465	0.00406	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MYH11—thoracic aortic aneurysm	0.000444	0.00388	CbGpPWpGaD
Minocycline—MMP9—Degradation of the extracellular matrix—MMP2—thoracic aortic aneurysm	0.000431	0.00377	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ADAM17—thoracic aortic aneurysm	0.000421	0.00368	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—MMP2—thoracic aortic aneurysm	0.000413	0.00361	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TGFBR2—thoracic aortic aneurysm	0.000405	0.00354	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—TGFB2—thoracic aortic aneurysm	0.000404	0.00353	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—TGFB2—thoracic aortic aneurysm	0.000404	0.00353	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MYH11—thoracic aortic aneurysm	0.000386	0.00337	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MMP9—thoracic aortic aneurysm	0.000372	0.00326	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—MMP9—thoracic aortic aneurysm	0.000366	0.0032	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP2—thoracic aortic aneurysm	0.000358	0.00313	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MMP9—thoracic aortic aneurysm	0.000337	0.00295	CbGpPWpGaD
Minocycline—CASP1—Immune System—PRKG1—thoracic aortic aneurysm	0.00033	0.00289	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—ADAM10—thoracic aortic aneurysm	0.000323	0.00282	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000274	0.0024	CbGpPWpGaD
Minocycline—CASP1—Immune System—ADAM17—thoracic aortic aneurysm	0.000274	0.00239	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—MMP9—thoracic aortic aneurysm	0.000269	0.00235	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PRKG1—thoracic aortic aneurysm	0.000262	0.00229	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP2—thoracic aortic aneurysm	0.00026	0.00227	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—ADAM10—thoracic aortic aneurysm	0.000238	0.00208	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB2—thoracic aortic aneurysm	0.000208	0.00182	CbGpPWpGaD
Minocycline—IL1B—Immune System—PRKG1—thoracic aortic aneurysm	0.000207	0.00181	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.000196	0.00171	CbGpPWpGaD
Minocycline—CASP3—Extracellular matrix organization—MMP9—thoracic aortic aneurysm	0.000196	0.00171	CbGpPWpGaD
Minocycline—MMP9—Extracellular matrix organization—MMP2—thoracic aortic aneurysm	0.000181	0.00158	CbGpPWpGaD
Minocycline—IL1B—Immune System—ADAM17—thoracic aortic aneurysm	0.000171	0.0015	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—ADAM10—thoracic aortic aneurysm	0.00017	0.00148	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.00016	0.0014	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—MMP2—thoracic aortic aneurysm	0.000153	0.00134	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000148	0.00129	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SMAD3—thoracic aortic aneurysm	0.000139	0.00121	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP2—thoracic aortic aneurysm	0.000133	0.00116	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADAM17—thoracic aortic aneurysm	0.000122	0.00107	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	0.000122	0.00107	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—MMP2—thoracic aortic aneurysm	0.000109	0.000956	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKG1—thoracic aortic aneurysm	0.000102	0.000895	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—MMP9—thoracic aortic aneurysm	0.0001	0.000874	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP2—thoracic aortic aneurysm	9.5e-05	0.00083	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ADAM10—thoracic aortic aneurysm	9.37e-05	0.000819	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKG1—thoracic aortic aneurysm	8.89e-05	0.000777	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	8.67e-05	0.000758	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADAM17—thoracic aortic aneurysm	8.49e-05	0.000742	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	8.49e-05	0.000742	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SMAD3—thoracic aortic aneurysm	7.67e-05	0.00067	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR1—thoracic aortic aneurysm	7.37e-05	0.000644	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADAM17—thoracic aortic aneurysm	7.37e-05	0.000644	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—thoracic aortic aneurysm	7.14e-05	0.000624	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADAM10—thoracic aortic aneurysm	6.5e-05	0.000568	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	6.02e-05	0.000526	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADAM10—thoracic aortic aneurysm	5.65e-05	0.000494	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SMAD3—thoracic aortic aneurysm	5.32e-05	0.000465	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFBR2—thoracic aortic aneurysm	5.22e-05	0.000457	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SMAD3—thoracic aortic aneurysm	4.62e-05	0.000404	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—thoracic aortic aneurysm	3.94e-05	0.000344	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—thoracic aortic aneurysm	2.37e-05	0.000208	CbGpPWpGaD
